EUVIMEDEUVIMED entdecken
Crossref

FDCA Attenuates Neuroinflammation and Brain Injury after Cerebral Ischemic Stroke

Xin Guan, Dasha Wei, Zhuangzhuang Liang, Luyang Xie, Yifang Wang, Zhangjian Huang iD, Jin Wu, Tao Pang iD

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Xin Guan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Center of Drug Discovery, New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Eval…. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke, Nervous System Diseases, Brain Injuries. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Government of Xinjiang Uygur Autonomous Region of China, China Pharmaceutical University, State Key Laboratory of Pharmaceutical Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeStrokeNervous System DiseasesBrain InjuriesBrain IschemiaRatsHumansAnimalsNeuroinflammatory DiseasesInfarction, Middle Cerebral ArteryBlood-Brain Barrier1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine

Stichwörter der Autor:innen

ROCKblood-brain barrier integritydichloroacetatefasudilischemic strokeneuroinflammation

Substanzen

fasudil1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Center of Drug Discovery, New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, P. R. China.
  • Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, P. R. China.

ORCID-Profile: Zhangjian Huang, Tao Pang

Förderung

  • Government of Xinjiang Uygur Autonomous Region of China
  • China Pharmaceutical University
  • State Key Laboratory of Pharmaceutical Biotechnology
  • National Natural Science Foundation of China

Zitieren

APA

Guan, X., Wei, D., Liang, Z., Xie, L., Wang, Y., Huang, Z., Wu, J., & Pang, T. (2023). FDCA Attenuates Neuroinflammation and Brain Injury after Cerebral Ischemic Stroke. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00456

Vancouver

Guan X, Wei D, Liang Z, Xie L, Wang Y, Huang Z, et al. FDCA Attenuates Neuroinflammation and Brain Injury after Cerebral Ischemic Stroke. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00456

BibTeX
@article{Guan2023,
  author = {Guan, Xin and Wei, Dasha and Liang, Zhuangzhuang and Xie, Luyang and Wang, Yifang and Huang, Zhangjian and Wu, Jin and Pang, Tao},
  title = {FDCA Attenuates Neuroinflammation and Brain Injury after Cerebral Ischemic Stroke},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00456}
}
Kostenlos starten →